Literature DB >> 10520001

Abnormalities of the p53 gene in juvenile myelomonocytic leukaemia.

J Miyauchi1, M Asada, Y Tsunematsu, Y Kaneko, S Kojima, S Mizutani.   

Abstract

Juvenile chronic myelomonocytic leukaemia (JMML) is a rare myeloproliferative disorder of childhood. Fewer than 30% of cases of JMML terminate in a blast crisis; however, its molecular mechanism is unknown. Since mutation and/or deletion of the p53 gene has been reported to be associated with disease progression in a wide variety of human cancers, including adult-type chronic myelogenous leukaemia, we studied the p53 gene in 20 patients with JMML (16 samples in chronic phase and seven at blast crisis). Exons 4-8 of the p53 gene, which cover all the hot spots of point mutations, were amplified by the polymerase chain reaction (PCR) method and subjected to mutation screening by single-strand conformation polymorphism analysis. No mobility shift of single-strand DNA of PCR products in polyacrylamide gel electrophoresis, indicating point mutations, was found in 19/20 patients. DNA of the remaining patient in the chronic phase failed to be amplified by PCR and Southern blot analysis with XbaI-digested genomic DNA revealed a gross rearrangement (presumed deletion) of the p53 gene. These data indicate that abnormalities of the p53 gene are rare in JMML and not responsible for acute transformation, but could be involved in the pathogenesis of some cases of JMML.

Entities:  

Mesh:

Year:  1999        PMID: 10520001     DOI: 10.1046/j.1365-2141.1999.01634.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.

Authors:  Stephen M Wiesner; Jennifer L Geurts; Miechaleen D Diers; Rachel J Bergerson; Diane E Hasz; Kelly J Morgan; David A Largaespada
Journal:  Am J Hematol       Date:  2011-07       Impact factor: 10.047

2.  Proteomic Analysis of an Induced Pluripotent Stem Cell Model Reveals Strategies to Treat Juvenile Myelomonocytic Leukemia.

Authors:  Stella Pearson; Baoqiang Guo; Andrew Pierce; Narges Azadbakht; Julie A Brazzatti; Stefano Patassini; Sonia Mulero-Navarro; Stefan Meyer; Christian Flotho; Bruce D Gelb; Anthony D Whetton
Journal:  J Proteome Res       Date:  2019-11-12       Impact factor: 4.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.